Feature | September 01, 2016| Dave Fornell

Most Popular DAIC Content in August 2016

Tidi, CFI, zero-gravity, zergravity, cath lab radiation protection

Concerns about cath lab staff exposure to X-ray radiation was one of the big drivers of DAIC reader interests in August. This image shows Tidi Products' Zero-Gravity system that provides twice the amount of protection of conventional lead aprons in the cath lab. The system is ceiling suspended so the physician does not have the weight on their back and shoulders and eliminates the need for the operator to wear lead. This system was one of the five radiation dose reduction technologies highlighted in the top article from this month. 

September 1, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of August based on website analytics:  

1. 5 Technologies to Reduce Cath Lab Radiation Exposure

2. Heart Surgeon Shares Effects of Fluoroscopic Radiation Exposure in ORSIF Documentary

3. FDA Expands Sapien TAVR Valve Indication to Intermediate-Risk Patients

4. First TAVR Device Receives European Approval to Treat Intermediate Risk Patients

5. Electronics Embedded in Bioresorbable Stents May Offer a New Direction for Revascularization

6. Update for LAA Occluder Technology News and Trends

7. FDA Clears Bioresorbable Vascular Closure Device

8. Osprey Receives $28 Million in Funding for its Cath Lab Contrast Reduction Technology

9. FDA Clears MRI-safe Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System

11. PFO Closure Not Recommended for People with Heart Defect and Stroke

12. FDA Clears Gore Tigris Vascular Stent for Treatment of Peripheral Artery Disease

13. New Technologies to Treat Peripheral Artery Disease (PAD)

14. VIDEO: How to Install a Subcutaneous ICD System

15. Update on Atherectomy System Technology

16. CMS Changes MitraClip Reimbursement Codes to Widen Patient Access

17. Role of Imaging in Bioresorbable Stent Procedures

18. Regular Exercise Can Lead to Heart Disease Misdiagnosis

19. Key Cardiac CT News and Trends From SCCT 2016

20. Tempering the Bioresorbable Stent Euphoria Following FDA Clearance of the Absorb


Read the article "Most Popular DAIC Content in July 2016."

Read the article "Most Popular DAIC Content in June 2016"


Related Content

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018
March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help impro
Videos | Cath Lab | March 15, 2018
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer
News | Cath Lab | February 27, 2018
The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to...
News | Cath Lab | February 23, 2018
February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary mi
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Overlay Init